Wang Jingjing, Chen Daonan, Deng Puyu, Zhang Chenchen, Zhan Xue, Lv Hui, Xie Hui, Chen Dechang, Wang Ruilan
Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.
Critical Care Medicine, Shanghai Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
J Intensive Med. 2023 Mar 30;3(4):365-72. doi: 10.1016/j.jointm.2023.02.001.
Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, prone positioning has been widely applied for non-intubated, spontaneously breathing patients. However, the efficacy and safety of prone positioning in non-intubated patients with COVID-19-related acute hypoxemic respiratory failure remain unclear. We aimed to systematically analyze the outcomes associated with awake prone positioning (APP).
We conducted a systematic literature search of PubMed/MEDLINE, Cochrane Library, Embase, and Web of Science from January 1, 2020, to June 3, 2022. This study included adult patients with acute respiratory failure caused by COVID-19. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed, and the study quality was assessed using the Cochrane risk-of-bias tool. The primary outcome was the reported cumulative intubation risk across randomized controlled trials (RCTs), and the effect estimates were calculated as risk ratios (RRs; 95% confidence interval [CI]).
A total of 495 studies were identified, of which 10 fulfilled the selection criteria, and 2294 patients were included. In comparison to supine positioning, APP significantly reduced the need for intubation in the overall population (RR=0.84, 95% CI: 0.74-0.95). The two groups showed no significant differences in the incidence of adverse events (RR=1.16, 95% CI: 0.48-2.76). The meta-analysis revealed no difference in mortality between the groups (RR=0.93, 95% CI: 0.77-1.11).
APP was safe and reduced the need for intubation in patients with respiratory failure associated with COVID-19. However, it did not significantly reduce mortality in comparison to usual care without prone positioning.
自2019冠状病毒病(COVID-19)大流行开始以来,俯卧位通气已广泛应用于未插管、自主呼吸的患者。然而,俯卧位通气在患有COVID-19相关急性低氧性呼吸衰竭的未插管患者中的疗效和安全性仍不明确。我们旨在系统分析清醒俯卧位通气(APP)的相关结果。
我们于2020年1月1日至2022年6月3日在PubMed/MEDLINE、Cochrane图书馆、Embase和科学网进行了系统的文献检索。本研究纳入了因COVID-19导致急性呼吸衰竭的成年患者。遵循系统评价和Meta分析的首选报告项目(PRISMA)指南,并使用Cochrane偏倚风险工具评估研究质量。主要结局是随机对照试验(RCT)中报告的累计插管风险,效应估计值计算为风险比(RRs;95%置信区间[CI])。
共识别出495项研究,其中10项符合入选标准,纳入2294例患者。与仰卧位通气相比,APP显著降低了总体人群的插管需求(RR=0.84,95%CI:0.74-0.95)。两组不良事件发生率无显著差异(RR=1.16,95%CI:0.48-2.76)。Meta分析显示两组死亡率无差异(RR=0.93,95%CI:0.77-1.11)。
APP是安全的,降低了COVID-19相关呼吸衰竭患者的插管需求。然而,与不采用俯卧位通气的常规治疗相比,它并未显著降低死亡率。